Lugovskoy; Alexey A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lugovskoy; Alexey A..The latest application filed is for "anti-vla-4 antibodies".
Company Profile
12.21.28
- Lugovskoy; Alexey A. - Woburn MA
- Lugovskoy; Alexey A. - Belmont MA
Patent Activity
| Patent | Date |
|---|---|
| Anti-vla-4 Antibodies App 20210401981 - Lugovskoy; Alexey A. ; et al. | 2021-12-30 |
| Antagonists of human integrin (.alpha.4)(.beta.7) Grant 11,174,228 - Bursavich , et al. November 16, 2 | 2021-11-16 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20210284640 - Harrison; Bryce A. ; et al. | 2021-09-16 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20210276975 - Brewer; Mark ; et al. | 2021-09-09 |
| Anti-VLA-4 antibodies Grant 11,083,791 - Lugovskoy , et al. August 10, 2 | 2021-08-10 |
| Inhibitors of (.alpha.-v)(.beta.-6) integrin Grant 11,046,685 - Harrison , et al. June 29, 2 | 2021-06-29 |
| Inhibitors of (.alpha.-v)(.beta.-6) integrin Grant 11,046,669 - Harrison , et al. June 29, 2 | 2021-06-29 |
| Inhibitors of (alpha-v)(beta-6) integrin Grant 11,040,955 - Brewer , et al. June 22, 2 | 2021-06-22 |
| Bruton's Tyrosine Kinase Inhibitors App 20200399283 - BUI; Minna ; et al. | 2020-12-24 |
| Antagonists Of Human Integrin (alpha4)(beta7) App 20200385352 - Bursavich; Matthew G. ; et al. | 2020-12-10 |
| Antagonists of human integrin .alpha.4.beta.7 Grant 10,759,756 - Bursavich , et al. Sep | 2020-09-01 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200157075 - Harrison; Bryce A. ; et al. | 2020-05-21 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200087299 - Brewer; Mark ; et al. | 2020-03-19 |
| Bruton's tyrosine kinase inhibitors Grant 10,577,374 - Bui , et al. | 2020-03-03 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200002334 - Harrison; Bryce A. ; et al. | 2020-01-02 |
| Anti-vla-4 Antibodies App 20190365892 - Lugovskoy; Alexey A. ; et al. | 2019-12-05 |
| Antagonists Of Human Integrin (alpha4)(beta7) App 20190315692 - Bursavich; Matthew G. ; et al. | 2019-10-17 |
| Anti-VLA-4 antibodies Grant 10,335,485 - Lugovskoy , et al. | 2019-07-02 |
| Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 10,072,299 - Bukhalid , et al. September 11, 2 | 2018-09-11 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20180244648 - Harrison; Bryce A. ; et al. | 2018-08-30 |
| Anti-vla-4 Antibodies App 20180221480 - Lugovskoy; Alexey A. ; et al. | 2018-08-09 |
| Bruton's Tyrosine Kinase Inhibitors App 20180065974 - BUI; Minna ; et al. | 2018-03-08 |
| Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,902,999 - Bukhalid , et al. February 27, 2 | 2018-02-27 |
| Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,885,087 - Bukhalid , et al. February 6, 2 | 2018-02-06 |
| Bruton's tyrosine kinase inhibitors Grant 9,790,229 - Bui , et al. October 17, 2 | 2017-10-17 |
| Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto Grant 9,738,707 - Taylor , et al. August 22, 2 | 2017-08-22 |
| Bruton's Tyrosine Kinase Inhibitors App 20160376281 - Bui; Minna ; et al. | 2016-12-29 |
| Bruton'S tyrosine kinase inhibitors Grant 9,249,146 - Bui , et al. February 2, 2 | 2016-02-02 |
| Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,226,964 - Bukhalid , et al. January 5, 2 | 2016-01-05 |
| Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150376284 - BUKHALID; Raghida ; et al. | 2015-12-31 |
| Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150368347 - BUKHALID; Raghida ; et al. | 2015-12-24 |
| Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150368346 - BUKHALID; Raghida ; et al. | 2015-12-24 |
| Anti-.alpha..sub..nu..beta..sub.6 antibodies and uses thereof Grant 8,992,924 - Violette , et al. March 31, 2 | 2015-03-31 |
| Heterodimeric Fc Regions, Binding Molecules Comprising Same, And Methods Relating Thereto App 20140341906 - Taylor; Frederick R. ; et al. | 2014-11-20 |
| Bruton's Tyrosine Kinase Inhibitors App 20140309212 - Bui; Minna ; et al. | 2014-10-16 |
| Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof App 20140294809 - Violette; Shelia M. ; et al. | 2014-10-02 |
| Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20140234314 - BUKHALID; Raghida ; et al. | 2014-08-21 |
| Bruton's tyrosine kinase inhibitors Grant 8,785,440 - Bui , et al. July 22, 2 | 2014-07-22 |
| Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20140127207 - BUKHALID; Raghida ; et al. | 2014-05-08 |
| Anti-lymphotoxin Antibodies App 20140079716 - RANGER; Ann M. ; et al. | 2014-03-20 |
| Bruton's Tyrosine Kinase Inhibitors App 20120157443 - Bui; Minna ; et al. | 2012-06-21 |
| Anti-lymphotoxin Antibodies App 20120003235 - Ranger; Ann M. ; et al. | 2012-01-05 |
| Anti-Alpha v Beta 6 Antibodies and Uses Thereof App 20110305629 - Violette; Shelia M. ; et al. | 2011-12-15 |
| Anti-.alpha..sub.v.beta..sub.6 antibodies and uses thereof Grant 7,943,742 - Violette , et al. May 17, 2 | 2011-05-17 |
| Anti-alpha(v)beta(6) antibodies and uses thereof App 20080286269 - Violette; Shelia M. ; et al. | 2008-11-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 